AIDS Patient Care STDS by Petrosky, Emiko et al.
Early Syphilis Among Men Who Have Sex with Men in the US 
Pacific Northwest, 2008–2013: Clinical Management and 
Implications for Prevention
Emiko Petrosky, MD, MPH1,2, Robyn Neblett Fanfair, MD, MPH2, Kim Toevs, MPH3, Malini 
DeSilva, MD, MPH1,4, Sean Schafer, MD, MPH4, Katrina Hedberg, MD, MPH4, Jim Braxton, 
AS, AA, ABCP2, Jaime Walters, MPH3, Lauri Markowitz, MD2, and Susan Hariri, PhD2
1Epidemic Intelligence Service, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB 
Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia
2Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB 
Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia
3Adolescent Health Promotion and STD/HIV/HCV Programs, Multnomah County Public Health 
Department, Portland, Oregon
4HIV/STD/TB Program, Center for Public Health Practice, Oregon Public Health Division, 
Portland, Oregon
Abstract
Substantial increases in syphilis during 2008–2013 were reported in the US Pacific Northwest 
state of Oregon, especially among men who have sex with men (MSM). The authors aimed to 
characterize the ongoing epidemic and identify possible gaps in clinical management of early 
syphilis (primary, secondary, and latent syphilis ≤1 year) among MSM in Multnomah County, 
Oregon to inform public health efforts. Administrative databases were used to examine trends in 
case characteristics during 2008–2013. Medical records were abstracted for cases occurring in 
2013 to assess diagnosis, treatment, and screening practices. Early syphilis among MSM increased 
from 21 cases in 2008 to 229 in 2013. The majority of cases occurred in HIV-infected patients 
(range: 55.6%–69.2%) diagnosed with secondary syphilis (range: 36.2%–52.4%). In 2013, 119 
(51.9%) cases were diagnosed in public sector medical settings and 110 (48.0%) in private sector 
settings. Over 80% of HIV-infected patients with syphilis were in HIV care. Although treatment 
was adequate and timely among all providers, management differed by provider type. Among 
HIV-infected patients, a larger proportion diagnosed by public HIV providers than private 
providers were tested for syphilis at least once in the previous 12 months (89.6% vs. 40.0%; p < 
0.001). The characteristics of MSM diagnosed with early syphilis in Multnomah County remained 
largely unchanged during 2008–2013. Syphilis control measures were well established, but early 
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syphilis among MSM continued to increase. The results suggest a need to improve syphilis 
screening among private clinics, but few gaps in clinical management were identified.
Introduction
Syphilis infections have increased in recent years internationally,1 as well as throughout the 
United States, especially among men who have sex with men (MSM).2–4 After sustained 
decreases to an all-time low in 2000, rates of primary and secondary syphilis in men in the 
United States increased from 3.0 cases per 100,000 population in 2001 to 9.8 in 2013.2,3 In 
2013, MSM accounted for 75% of primary and secondary syphilis cases in 49 states and the 
District of Columbia that provided information about sex of sex partners.2 The surge in 
syphilis among MSM is troubling, considering the morbidity associated with untreated 
syphilis, including neurosyphilis and cardiovascular sequelea.5 Furthermore, syphilis is 
associated with both HIV transmission and acquisition,6–9 and a disproportionate number of 
syphilis diagnoses occur in HIV-infected MSM.10,11
Control of syphilis requires early detection and treatment to prevent further transmission. 
During the early stages when patients are most infectious, patients and clinicians may not 
recognize signs and symptoms (i.e., painless chancre, atypical rash) as syphilis;12 thus, a key 
control measure is routine screening, including routine screening of MSM for syphilis.13,14 
Current guidelines recommend at least annual screening of all sexually active MSM for 
sexually transmitted diseases (STD).15 For MSM at higher risk of acquiring STDs, more 
frequent screening may be indicated.15,16
Between 2008 and 2013, the state of Oregon in the Pacific Northwest United States 
experienced a greater than 8-fold increase in the incidence of early syphilis, from 1.2 to 10.1 
cases per 100,000 population;2,17 58% of cases occurred among residents of Multnomah 
County, and 95% of these cases were among MSM. Multnomah County is the most 
populous county in Oregon and includes the city of Portland.
Despite coordinated public health measures to increase awareness among the populations at 
risk and dissemination of information about the epidemic through letters to providers, public 
announcements, and citywide infectious disease grand rounds, rates of early syphilis in 
Multnomah County continued to increase. In this investigation, we examined demographic 
and clinical characteristics of early syphilis among MSM residents of Multnomah County 
during 2008 through 2013, and evaluated clinical management of MSM diagnosed in 2013 
by stage of infection and HIV status. Our aims were to characterize the ongoing epidemic 
and to identify possible gaps in clinical management to guide future public health 
interventions.
Methods
Oregon regulations mandate health-care providers to report suspected syphilis cases, and 
laboratories to report positive treponemal and nontreponemal syphilis tests to the local 
health department.18 Syphilis tests include nontreponemal serologic tests [rapid plasma 
reagin (RPR) and veneral disease research laboratory (VDRL) tests] and treponemal tests 
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[fluorescent treponemal antibody absorption (FTA-ABS) test, treponema pallidum particle 
agglutination assay (TPPA) test, and enzyme immunoassay (EIA)]. Confirmed and 
suspected syphilis cases, identified using either traditional or reverse sequence syphilis 
testing algorithms, are investigated through a structured interview to elicit demographic, 
behavioral, and clinical information, ensure appropriate treatment, and identify sex partners 
who may have been exposed. Data are recorded on a standardized form and entered into the 
Multnomah County Health Department (MCHD) electronic database.
Study Population
We used the MCHD reportable disease database to identify male residents of Multnomah 
County with clinical or laboratory confirmed diagnosis of early syphilis (primary, secondary, 
or latent syphilis ≤1 year) during January 1, 2008 through December 31, 2013 and who self-
reported oral/anal sex with a man in the 12 months before their syphilis diagnosis.
Data Collection
For cases diagnosed during 2008 through 2013, we used the MCHD database to extract 
demographic and clinical data, including age, race/ethnicity, stage of infection, and HIV 
status. HIV status is self-reported or laboratory-confirmed in the MCHD database. For cases 
diagnosed in 2013, we abstracted medical records for incident syphilis infections from 
public and private clinics that reported the cases. An incident syphilis infection was defined 
as the first time a case patient had a reactive RPR test and evidence of a confirmed or 
presumptive infection in the medical record in 2013.
Data collected include stage of infection, history of syphilis, previous syphilis tests, signs 
and symptoms on exam, evidence of more than one provider visit before diagnosis (as 
determined by documented self-report or multiple provider visits for the same signs and 
symptoms), RPR titer at diagnosis, diagnosing and treating providers, treatment received, 
duration from syphilis test to initial treatment, and laboratory-confirmed HIV status. We 
collected both diagnosing and treating providers to assess patients who received treatment 
from a different clinic than where they were diagnosed.
For HIV-uninfected patients, HIV testing at the time of the syphilis test and use of pre-
exposure prophylaxis (PrEP) were collected. For HIV-infected patients, antiretroviral (ARV) 
use, HIV RNA, and CD4 count were collected from the state reportable disease database. To 
assess routine testing practices, we compared syphilis testing in the previous 12 months 
among HIV-infected MSM diagnosed with syphilis by the MCHD public HIV clinic to other 
clinic settings. The MCHD public STD clinic was not included in this analysis as this clinic 
performs only episodic, not routine, care.
We classified providers by type of clinic as follows: MCHD public STD clinic as “STD 
Providers,” MCHD public HIV clinic as “HIV Providers,” and other clinic types including 
one large academic center, three large medical systems/managed care organizations, two 
private practice primary care clinics, and one public primary care clinic as “ Other 
Providers.” Stage of infection was categorized as primary, secondary, and early latent 
syphilis using Centers for Disease Control and Prevention (CDC) surveillance case 
definitions for syphilis.2
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For cases diagnosed during 2008 through 2013, trends in case characteristics by year of 
diagnosis were examined in 2-year increments due to small sample sizes in 2008 and 2009. 
To examine categorical variables, we used the Cochran-Mantel-Haenszel test with 
nonparametric modified ridit scores; this test is similar to the non-parametric Wilcoxon test 
and enhances the analysis when the parameter is not normally distributed.19,20 For 
continuous variables, the Spearman's rank correlation was used.
For cases diagnosed in 2013, only the incident diagnosis for individuals with more than one 
syphilis diagnosis during 2013 was used for analysis; because only incident syphilis 
infections were used, we refer to these cases as patients. Descriptive analyses were used to 
assess clinical management, including diagnosis, treatment, and screening. Differences by 
provider type and HIV status were examined using χ2 test or Fisher's exact test for 
proportions and Wilcoxon test for medians. One patient with newly diagnosed HIV at the 
time of the syphilis test was excluded because he would not have had an opportunity to be in 
HIV care, unlike cases with a known history of HIV. All statistical analyses were conducted 
using SAS version 9.3 (SAS Institute, Inc., Cary, NC).
This evaluation was determined to be public health practice and not constitute human 
subjects research according to the criteria from the Office of Research Protection by the 
Oregon Health Authority and according to the Human Subject Review's decision code by 
CDC's Epidemiology Program Office; therefore, the evaluation did not require IRB review.
Results
Demographic and clinical characteristics of MSM diagnosed with early syphilis during 
2008–2013
From 2008 to 2013, a total of 663 cases of early syphilis were diagnosed in MSM in 
Multnomah County; the number of cases increased each year from 21 in 2008 to 229 in 
2013 (Fig. 1). Case distribution by stage of infection did not change significantly over time 
(ptrend = 0.713). Across all years, most cases occurred in non-Hispanic whites (72.3% in 
2008–2009, 75.7% in 2010–2011, and 72.0% in 2012–2013). Median age increased 
significantly from 36 years (interquartile range (IQR): 30–44) in 2008–2009 to 39 years 
(IQR: 31–48) in 2012–2013 (ptrend = 0.009). Most patients were HIV-infected, and the 
proportion of cases among HIV-infected patients increased from 55.6% during 2008–2009 to 
69.2% during 2012–2013 (ptrend = 0.016).
Clinical characteristics and management of MSM diagnosed with early syphilis in 2013
In 2013, a total of 229 cases of early syphilis were diagnosed among MSM, 119 (51.9%) in 
public sector medical settings and 110 (48.0%) in private sector settings. Medical records 
were available for all 64 cases diagnosed by STD providers, all 52 cases diagnosed by HIV 
providers, and 87 (77%) cases diagnosed by other providers. Ten patients were diagnosed 
with syphilis twice in 2013. Among the remaining 193 incident cases, 24.9% were primary, 
42.5% were secondary, and 32.6% were early latent syphilis (Table 1).
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Median time to treatment differed by stage of infection; most patients with primary syphilis 
received treatment on the same day they were tested for syphilis (median 0 day, IQR: 0–2 
days), whereas most patients with secondary syphilis received treatment a median of 2 days 
(IQR: 0–4 days), and with early latent syphilis a median of 3 days (IQR: 1–6 days) after 
their syphilis test (p < 0.001). Three (6.3%) patients with primary syphilis and 19 (23.3%) 
patients with secondary syphilis had more than one provider visit for the same symptoms 
before diagnosis, and several misdiagnoses were noted in the medical chart. Misdiagnoses 
for patients subsequently diagnosed with primary syphilis included chancroid and herpes 
simplex virus and for secondary syphilis included contact dermatitis, eczema, allergy, 
pityriasis rosea, scarlet fever, and scabies.
Clinical management differed by provider type (Table 1). All patients received treatment for 
syphilis; 83.3% were treated with one dose of benzathine penicillin, 11.0% with three doses 
of benzathine penicillin, and 5.8% with doxy-cycline. Most patients diagnosed by STD 
providers received treatment on the same day they were tested for syphilis (median 0 day, 
IQR: 0–3 days), whereas most patients diagnosed by HIV providers received treatment the 
next day (median 1 day, IQR: 0–5 days), and those diagnosed by other providers a median of 
3 days (IQR: 1–6 days) after their syphilis test (p < 0.001). Receipt of treatment in a clinic 
different from the diagnosing clinic occurred in 15.9% of patients diagnosed by other 
providers, 3.3% diagnosed by STD providers, and 2.1% diagnosed by HIV providers (p = 
0.006); of these, all patients diagnosed by other providers and HIV providers received 
treatment from STD providers.
Patient characteristics and clinical management also differed by HIV status. A total of 128 
(66.3%) patients were HIV-infected at the time of their syphilis test (Table 2). HIV-infected 
patients were older than HIV-uninfected patients (median age 41 vs. 33 years; p = 0.001), 
but did not differ by race/ethnicity. HIV-infected patients were more likely to have a history 
of past syphilis infection compared with HIV-uninfected patients (39.8% vs. 10.8%; p 
<0.001). Most HIV-infected patients were diagnosed with early latent syphilis, while most 
HIV-uninfected patients were diagnosed with secondary syphilis (p = 0.004). There were 
three cases of neurosyphilis, all among HIV-infected patients; two in patients with secondary 
syphilis and one in a patient with early latent syphilis. There were no cases of ocular 
syphilis.
Median RPR titer at diagnosis was higher among HIV-infected patients compared with HIV-
uninfected patients (1:64 vs. 1:32; p < 0.001). Most (80.0%) HIV-uninfected patients 
underwent HIV testing at the time of their syphilis test, 2 (3.1%) were documented to be on 
PrEP, and 38.3% had been tested for syphilis at least once in the previous 12 months. The 
majority (84.4%) of HIV-infected patients were documented to be on ARV and 99.2% had 
HIV RNA or CD4 count within the previous 6 months.
We further investigated syphilis testing among HIV-infected patients in the previous 12 
months. More HIV-infected patients diagnosed with syphilis by HIV providers than other 
providers were tested for syphilis at least once in the previous 12 months (89.6% vs. 40.0%; 
p < 0.001), and a larger proportion were tested more frequently (≥2 tests, 3 to 6 months 
apart) by HIV providers than other providers (75.0% vs. 29.2%; p < 0.001).
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Our findings indicate that while the number of reported early syphilis cases among MSM 
residents of Multnomah County increased during 2008 through 2013, their demographic and 
clinical characteristics remained largely unchanged. A recent study using nationally 
representative data found racial/ethnic disparities in HIV and STDs, with black and Hispanic 
adults in the United States having a higher burden of HIV and STDs than their white 
counterparts.21
In contrast to the increase in syphilis seen in predominantly young MSM of color in most 
metropolitan areas of the United States,3 MSM with early syphilis in Multnomah County 
tended to be older (>30 years of age) and non-Hispanic white. These differences likely 
mirror characteristics of the overall MSM population of Multnomah County. Our finding 
that over half of MSM with early syphilis in Multnomah County were HIV infected is 
congruent with national data and may reflect the larger syndemic of STD and HIV among 
MSM across the United States3 and in other high income coun-tries.10,11 In many developed 
countries, a high percentage of syphilis cases in MSM occur in HIV-infected MSM,10,11 and 
the re-infection risk in these men is high.11
Many of the MSM with early syphilis in Multnomah County, including almost half with 
HIV infection, were diagnosed at private clinics or large medical centers. Almost all HIV-
infected MSM were in care and had undetectable viral load, indicating high health care 
utilization and good compliance with HIV medications. This should provide an ideal 
opportunity for early detection and treatment of syphilis. However, nearly a quarter of MSM 
with secondary syphilis had more than one provider visit for the same symptoms before 
diagnosis, suggesting missed opportunities for diagnosis, and several misdiagnoses were 
observed during medical records review. In most instances, this occurred in patients seen in 
private practice clinic settings whose providers may be less likely to conduct sexual histories 
or may be unfamiliar with signs and symptoms of syphilis.
This study did not specifically evaluate reasons for the increase in syphilis in Multnomah 
County; however, similar increases are occurring in MSM across the United States.2 The 
increasing use of PrEP to prevent HIV infection among HIV-uninfected MSM has been 
implicated in the rise in non-HIV STDs.22 In our study, only a small percentage of MSM 
with syphilis infection were on PrEP. Assessment of PrEP use and STD rates among MSM 
in Multnomah County should be considered if PrEP use becomes more widespread in this 
community.
Patients with untreated syphilis during the infectious early stages may transmit the disease 
and remain at risk for progression to serious complications including neurosyphilis. The 
majority of cases in Multnomah County were treated in a timely manner,23 especially at the 
public STD clinic where most patients received treatment on the same day as their syphilis 
test. However, among patients diagnosed in private clinic settings, median time to treatment 
for secondary syphilis was three days. The delay in treatment may be due to the lag in test 
results from private clinics where syphilis rapid RPR tests are not performed, private 
providers waiting for confirmatory test results before administering treatment, or from the 
larger proportion of cases in private clinics referred to the public STD clinic for treatment.
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Providers in non-STD clinic settings may not stock benzathine penicillin, relying instead on 
referrals for treatment at the public STD clinic. One strategy to facilitate prompt treatment 
could be delivery of penicillin to community clinics by public health staff.24 Field interviews 
and partner management services could then be performed on the same day the patient 
receives treatment in these clinics.
Our findings also suggest missed opportunities for syphilis screening, especially considering 
the high access to care in this population. The majority of MSM were diagnosed while 
symptomatic, and the proportion of asymptomatic cases diagnosed with early latent syphilis 
did not increase over time as might be expected if more screening was being performed.14 
Sexually active MSM should be screened at least annually for HIV infection and syphilis,15 
with more frequent HIV and STD testing (every 3–6 months) for MSM at highest risk.25
In studies assessing provider adherence to national guidelines for STD screening among 
HIV-infected MSM in HIV clinics in the United States, the annual syphilis screening rates 
ranged from 54% to 76%.26,27 More frequent syphilis screening occurs even less, with one 
study finding only 20% of HIV-infected MSM in the United States had documentation of 
repeat tests (≥2 tests, >3 months apart) within the previous 12 months.27 Mathematical 
models suggest increasing the frequency of syphilis screening among the highest risk MSM 
would have a greater impact on reducing the transmission and prevalence of syphilis 
compared with increasing the proportion of MSM tested for syphilis at least once per 
year.16,28
In our investigation, we found that providers at the public HIV clinic appeared to be 
routinely screening for syphilis, as suggested by the large proportion of MSM having 
evidence of prior syphilis testing and the high percentage diagnosed with early latent 
syphilis. However, among HIV-infected MSM diagnosed by private providers, fewer than 
half were documented to have been tested for syphilis in the previous 12 months.
A recent study found that providers often fail to include HIV and STD counseling and 
testing during routine health care visits for at-risk persons,29 citing individual and 
institutional barriers, including lack of training and discomfort with conducting a sexual 
history, lack of time to address sexual health risks, and lack of knowledge for screening 
reimbursements for HIV/STD.30 To increase STD/HIV screening of MSM by private 
providers, structural interventions such as screening protocols, reminder systems, chart 
prompts in electronic medical records, or automatic testing for syphilis when other tests are 
ordered, may be useful.31–33
Our assessment is subject to some limitations. First, cases whose medical charts were 
available for review may have differed from those whose records were not reviewed. More 
of the charts reviewed were for HIV-infected MSM in care, whereas more of the charts not 
reviewed were from small public and private clinics that see more HIV-uninfected MSM. 
Second, we were unable to account for within-subject correlation in the analysis of years 
2008 through 2013 because it was not possible to de-duplicate cases in the MCHD database.
However, for 2013, the year in which we could delineate individual patients, there were only 
10 MSM with repeat syphilis infections. Finally, some patients may have sought STD 
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screening at a clinic outside of their usual service provider rather than from their primary 
care or HIV care provider due to concerns of confidentiality or cost of testing. We were able 
to account for patients who attended the public STD or HIV clinics as we included all 
laboratory data from these sites in our analysis.
In summary, syphilis control measures in Multnomah County were largely well established 
during this investigation, but the rates of early syphilis among MSM continued to increase. 
Our analysis identified some need to increase provider knowledge to prevent delays in 
diagnosis, and the need to improve syphilis screening in private clinic settings. Otherwise, 
we found few gaps in clinical management that could have contributed to the dramatic 
increase seen in this population. Other studies have similarly found, even in settings with 
substantial resources, syphilis among MSM remains a stubborn problem.1
In addition to better recognition of signs and symptoms during physical examinations and 
implementation of screening recommendations, especially among clinicians in private 
practice,34 successful control of syphilis among MSM might require biomedical 
interventions that are sustained and tailored to the given population.
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Early syphilis cases among men who have sex with men (MSM) by stage of infection, 
Multnomah County, 2008–2013 (n = 663). Ptrend = 0.713; determined by Cochran-Mantel-
Haenszel test with nonparametric modified ridit scores.
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Table 2
Characteristics of Men Who Have Sex With Men (MSM) with Early Syphilis by HIV 
Status, Multnomah County, 2013 (n =193)
Characteristic HIV infected (n = 128) HIV uninfected (n = 65) pa
Median age in years (IQR) 41 (34–48) 33 (25–45) 0.001
Race/ethnicity, n (%) 0.291
 White, non-Hispanic 95 (74.2) 44 (67.7)
 Black, non-Hispanic 6 (4.7) 4 (6.2)
 Hispanic 22 (17.2) 10 (15.4)
 Other 5 (3.9) 7 (10.8)
History of syphilis, n (%) 51 (39.8) 7 (10.8) <0.001
Stage of infection, n (%) 0.004
 Primary 27 (21.1) 21 (32.3)
 Secondary 49 (38.3) 33 (50.8)
 Early latent 52 (40.6) 11 (16.9)
Reason for exam, n (%) 0.020
 Asymptomatic 24 (19.1) 2 (3.2)
 Symptomatic for STD-related symptoms 89 (70.6) 51 (81.0)
 Contact 13 (10.3) 10 (15.9)
Diagnosing provider, n (%) <0.001
 STD providers 15 (11.7) 47 (72.3)
 HIV providers 48 (37.5) 0
 Other providers 65 (50.8) 18 (27.7)
RPR, median titer (IQR) 1:64 (1:16–1:128) 1:32 (1:16–1:64) <0.001
Treatment, n (%) 0.268
 Benzathine penicillin (1 dose) 101 (78.9) 58 (89.2)
 Benzathine penicillin (3 doses) 16 (12.5) 5 (7.7)
 Doxycycline 9 (7.0) 2 (3.1)
HIV testing, n (%) – 52 (80.0) –
PrEP use, n (%) – 2 (3.1) –
ARV useb, n (%) 108 (84.4) – –
HIV RNA or CD4 count in previous 6 months, n (%) 127 (99.2) – –
 HIV RNA ≤50 copies/mL, n (%) 82 (66.7) – –
 Median CD4 cell count/mm3 (IQR) 518 (378–726) – –
a
Determined by χ2 test or Fisher's exact test for categorical variables and Wilcoxon test for medians.
b
Within 1 week before syphilis test date as documented in medical record. Numbers might not sum to column totals because of missing data.
ARV, antiretroviral; IQR, interquartile range; PrEP, pre-exposure prophylaxis; STD, sexually transmitted disease.
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